Skip to main content

Table 9 Bivariate analysis: clinical characteristics and mortality

From: Serologic and urinary characteristics of laboratory-confirmed genitourinary tuberculosis at a tertiary hospital in the Philippines

Characteristic

Category

Mortality

p value

Survived

Expired

Count

Row %

Count

Row %

Gender

Male

48

92.3

4

7.7

1.000

Female

55

91.7

5

8.3

Age

0 months to 1 year

0

0.0

1

100.0

<0.001

1–5 years

0

0.0

2

100.0

6–10 years

4

100.0

0

0.0

11–18 years

17

94.4

1

5.6

19–29 years

19

90.5

2

9.5

30–49 years

33

94.3

2

5.7

50–69 years

26

96.3

1

3.7

≥ 70 years

4

100.0

0

0.0

Marital status

Single/widowed

63

91.3

6

8.7

1.000

Married

40

93.0

3

7.0

Occupation

Employed

18

94.7

1

5.3

0.394

Unemployed

54

93.1

4

6.9

Not applicable

22

84.6

4

15.4

Unspecified

9

100.0

0

0.0

Location

City

55

91.7

5

8.3

0.834

Province

44

91.7

4

8.3

Unspecified

4

100.0

0

0.0

Co-morbidity

Yes

50

94.3

3

5.7

0.495

No

53

89.8

6

10.2

Diabetes mellitus

Yes

5

100.0

0

0.0

1.000

No

98

91.6

9

8.4

Hypertension

Yes

13

100.0

0

0.0

0.595

No

90

90.9

9

9.1

Chronic kidney disease

Yes

4

80.0

1

20.0

0.347

No

99

92.5

8

7.5

History of urolithiasis

Yes

8

100.0

0

0.0

1.000

No

95

91.3

9

8.7

Malignancy

Yes

1

100.0

0

0.0

1.000

No

102

91.9

9

8.1

HIV/AIDS

Yes

10

83.3

2

16.7

0.247

No

93

93.0

7

7.0

Steroid use

Yes

9

100.0

0

0.0

1.000

No

94

91.3

9

8.7

Systemic lupus erythematosus

Yes

8

100.0

0

0.0

1.000

No

95

91.3

9

8.7

Nephrotic syndrome

Yes

1

100.0

0

0.0

1.000

No

102

91.9

9

8.1

Cerebrovascular disease

Yes

1

100.0

0

0.0

1.000

No

102

91.9

9

8.1

Coronary artery disease

No

103

92.0

9

8.0

No test*

Heart failure

Yes

2

100.0

0

0.0

1.000

No

101

91.8

9

8.2

COPD

Yes

1

100.0

0

0.0

1.000

No

102

91.9

9

8.1

Bronchial asthma

Yes

2

100.0

0

0.0

1.000

No

101

91.8

9

8.2

Spina bifida

No

103

92.0

9

8.0

No test*

RTA Type 1

Yes

1

100.0

0

0.0

1.000

No

102

91.9

9

8.1

Previous TB

Yes

14

100.0

0

0.0

0.599

No

89

90.8

9

9.2

Other organ involvement of TB

Yes

57

89.1

7

10.9

0.296

No

46

95.8

2

4.2

Pulmonary TB

Yes

50

87.7

7

12.3

0.162

No

53

96.4

2

3.6

Gastrointestinal TB

Yes

24

85.7

4

14.3

0.224

No

79

94.0

5

6.0

Abdominopelvic TB

Yes

11

100.0

0

0.0

0.595

No

92

91.1

9

8.9

CNS TB

Yes

6

85.7

1

14.3

0.453

No

97

92.4

8

7.6

Bone TB

Yes

3

75.0

1

25.0

0.288

No

100

92.6

8

7.4

Cutaneous/Wound TB

Yes

3

100.0

0

0.0

1.000

No

100

91.7

9

8.3

TB Adenitis

Yes

7

87.5

1

12.5

0.500

No

96

92.3

8

7.7

Ear TB

Yes

1

50.0

1

50.0

0.155

No

102

92.7

8

7.3

Psoas TB

Yes

1

50.0

1

50.0

0.155

No

102

92.7

8

7.3

Dysuria

Yes

7

100.0

0

0.0

1.000

No

82

90.1

9

9.9

Hematuria

Yes

7

77.8

2

22.2

0.192

No

82

92.1

7

7.9

Urinary retention

Yes

1

100.0

0

0.0

1.000

No

88

90.7

9

9.3

Flank pain

Yes

11

100.0

0

0.0

0.592

No

78

89.7

9

10.3

Inguinal pain

Yes

1

100.0

0

0.0

1.000

No

88

90.7

9

9.3

Umbilical discharge

Yes

3

100.0

0

0.0

1.000

No

86

90.5

9

9.5

Fistula (uretero-cutaneous fistula)

Yes

1

100.0

0

0.0

1.000

No

88

90.7

9

9.3

Scrotal discharge

Yes

1

100.0

0

0.0

1.000

No

88

90.7

9

9.3

Double J stent reinsertion

Yes

1

100.0

0

0.0

1.000

No

88

90.7

9

9.3

Pedal edema

Yes

4

100.0

0

0.0

1.000

No

85

90.4

9

9.6

Fever

Yes

7

100.0

0

0.0

1.000

No

82

90.1

9

9.9

Weakness

Yes

14

93.3

1

6.7

1.000

No

75

90.4

8

9.6

Abdominal pain

Yes

6

75.0

2

25.0

0.157

No

83

92.2

7

7.8

Abdominal/pelvic mass on diagnostic

Yes

4

100.0

0

0.0

1.000

No

85

90.4

9

9.6

Vaginal bleeding

Yes

2

100.0

0

0.0

1.000

No

87

90.6

9

9.4

Difficulty of breathing

Yes

10

83.3

2

16.7

0.303

No

79

91.9

7

8.1

Others

Yes

9

81.8

2

18.2

0.266

No

80

92.0

7

8.0

  1. Bold values indicate statistically significant differences
  2. *No test was done since all patients were classified under the No category
  3. COPD chronic obstructive pulmonary disease, HIV/AIDS human immunodeficiency virus or acquired immunodeficiency syndrome, RTA Type 1 renal tubular acidosis Type 1, TB tuberculosis, y year